Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6171684de68ce62ef3fbf1655618249 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
filingDate |
2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ba90122ea3345eb741803680b59c9de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b85f88364ddc6a738edbd4461568bf6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc30479a284d95f1f31340a5662f4be3 |
publicationDate |
2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150112646-A |
titleOfInvention |
Composition for preventing or treating calcium ion-related muscle disease using materials inhibiting heteromerization between TRPC3 and TRPC1 |
abstract |
The present invention relates to the use of a substance that inhibits the formation of a heterotypic complex between TRPC3 (canonical-type transient receptor potential cation channel 3) and TRPC1 (canonical-type transient receptor potential cation channel 1) ≪ / RTI > |
priorityDate |
2014-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |